$922 Million is the total value of VR Adviser, LLC's 28 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CNST | CONSTELLATION PHARMACEUTICAL | $93,955,000 | -18.8% | 4,016,873 | 0.0% | 10.19% | -40.1% | |
| OLMA | OLEMA PHARMACEUTICALS INC | $50,971,000 | -31.0% | 1,536,193 | 0.0% | 5.53% | -49.1% | |
| KNTE | KINNATE BIOPHARMA INC | $45,899,000 | -21.7% | 1,473,014 | 0.0% | 4.98% | -42.2% | |
| TRILLIUM THERAPEUTICS INC | $43,390,000 | -27.0% | 4,040,000 | 0.0% | 4.71% | -46.1% | ||
| ATHA | ATHIRA PHARMA INC | $31,126,000 | -46.3% | 1,691,623 | 0.0% | 3.38% | -60.4% | |
| KURA | KURA ONCOLOGY INC | $16,255,000 | -13.4% | 575,000 | 0.0% | 1.76% | -36.1% | |
| COGT | COGENT BIOSCIENCES INC | $9,560,000 | -21.8% | 1,088,817 | 0.0% | 1.04% | -42.3% | |
| BCTG | BCTG ACQUISITION CORP | $5,560,000 | -2.8% | 500,000 | 0.0% | 0.60% | -28.3% | |
| VRDN | VIRIDIAN THERAPEUTICS INC | $326,000 | +1.6% | 19,495 | 0.0% | 0.04% | -25.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 12 | Q3 2023 | 12.7% |
| VIRIDIAN THERAPEUTICS INC | 12 | Q3 2023 | 13.4% |
| COGENT BIOSCIENCES INC | 12 | Q3 2023 | 10.3% |
| RELMADA THERAPEUTICS INC | 11 | Q3 2022 | 9.9% |
| GH RESEARCH PLC | 10 | Q3 2023 | 6.7% |
| ALTIMMUNE INC | 9 | Q3 2022 | 11.6% |
| MARINUS PHARMACEUTICALS INC | 9 | Q4 2022 | 5.7% |
| CELLDEX THERAPEUTICS INC | 9 | Q3 2022 | 7.6% |
| AFFIMED N V | 8 | Q3 2023 | 1.1% |
| INSTIL BIO INC | 7 | Q3 2022 | 18.7% |
View VR Adviser, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View VR Adviser, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.